Edwards Lifesciences (EW) Stock Price & AI Analysis
NYSE
$71.53
-$1.06 (-0.45%)
Subscribe to get AI Score
Market Cap 42.19B
Volume
3.67M
Avg Volume
5.94M
Target Price $96.59
52W Range
58.93 - 96.12
RSI (14) 56.2
Beta 1.13
PEG Ratio 1.47
SMA 20
2.57
SMA 50
4.36
SMA 200
-9.42
Insider Owner 1.7%
Insider Trans -0.65%
Institution Owner 84.51%
Institution Trans -2.25%
Short Interest 6.87%
EPS next Y -4.81
Edwards Lifesciences Company Profile
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Analyst recommendations
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Edwards Lifesciences Co. (NYSE:EW – Free Report) – Investment analysts at William Blair reduced their FY2024 earnings per share (EPS) estimates for shares of Edwards Lifesciences in a report ...